rs557697540
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001166110.2(PALLD):c.479G>C(p.Gly160Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000304 in 1,514,546 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001166110.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152192Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000627 AC: 7AN: 111722Hom.: 0 AF XY: 0.0000810 AC XY: 5AN XY: 61710
GnomAD4 exome AF: 0.0000279 AC: 38AN: 1362236Hom.: 2 Cov.: 35 AF XY: 0.0000417 AC XY: 28AN XY: 671564
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152310Hom.: 1 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74464
ClinVar
Submissions by phenotype
Pancreatic adenocarcinoma Uncertain:1
This variant is present in population databases (rs557697540, gnomAD 0.03%). This sequence change replaces glycine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 160 of the PALLD protein (p.Gly160Ala). This variant has not been reported in the literature in individuals affected with PALLD-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 580788). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at